Inflammation in first‐episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta‐analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammation in first‐episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta‐analysis
Authors
Keywords
-
Journal
ACTA PSYCHIATRICA SCANDINAVICA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-02-25
DOI
10.1111/acps.13416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort
- (2021) Benjamin I. Perry et al. SCHIZOPHRENIA RESEARCH
- Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
- (2020) David R. Goldsmith et al. Frontiers in Psychiatry
- Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia
- (2020) Shiguang Zhu et al. PSYCHONEUROENDOCRINOLOGY
- Different serum protein factor levels in first‐episode drug‐naive patients with schizophrenia characterized by positive and negative symptoms
- (2020) Nan Dai et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
- (2019) Jochen Kindler et al. MOLECULAR PSYCHIATRY
- Cytokine Alterations in Schizophrenia: An Updated Review
- (2019) Sara Momtazmanesh et al. Frontiers in Psychiatry
- Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study
- (2018) Dorota Frydecka et al. BRAIN BEHAVIOR AND IMMUNITY
- Kynurenine is correlated with IL-1β in plasma of schizophrenia patients
- (2018) Helena P. G. Joaquim et al. JOURNAL OF NEURAL TRANSMISSION
- Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia
- (2018) Mei-Hong Xiu et al. PSYCHIATRY RESEARCH
- Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
- (2018) Norbert Müller SCHIZOPHRENIA BULLETIN
- Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia
- (2018) Furong Zhu et al. Frontiers in Neuroscience
- IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
- (2018) Milica M. Borovcanin et al. Frontiers in Psychiatry
- Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis
- (2018) David Fraguas et al. SCHIZOPHRENIA BULLETIN
- TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia
- (2018) David R. Goldsmith et al. SCHIZOPHRENIA RESEARCH
- Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
- (2018) David R. Goldsmith et al. BRAIN BEHAVIOR AND IMMUNITY
- Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis
- (2018) Mariane Nunes Noto et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
- (2018) Toby Pillinger et al. SCHIZOPHRENIA BULLETIN
- Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
- (2017) Alexandre K Wang et al. SCHIZOPHRENIA BULLETIN
- Secondary negative symptoms — A review of mechanisms, assessment and treatment
- (2017) Matthias Kirschner et al. SCHIZOPHRENIA RESEARCH
- Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study
- (2016) Peter S. Bloomfield et al. AMERICAN JOURNAL OF PSYCHIATRY
- Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia
- (2016) Şeref Şimşek et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Clinical studies of neuroinflammatory mechanisms in schizophrenia
- (2016) Crystal C. Watkins et al. SCHIZOPHRENIA RESEARCH
- The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
- (2015) G.Z. Réus et al. NEUROSCIENCE
- Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia
- (2015) Milica Borovcanin et al. PSYCHONEUROENDOCRINOLOGY
- Effects of depression on the cytokine profile in drug naïve first-episode psychosis
- (2015) Cristiano Noto et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index
- (2015) Liina Haring et al. SCHIZOPHRENIA RESEARCH
- Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort
- (2015) Stephen F. Austin et al. SCHIZOPHRENIA RESEARCH
- Relationship between Interleukin-6 Gene Polymorphism and Hippocampal Volume in Antipsychotic-Naïve Schizophrenia: Evidence for Differential Susceptibility?
- (2014) Sunil Vasu Kalmady et al. PLoS One
- Activation of Th17 cells in drug naïve, first episode schizophrenia
- (2014) Minli Ding et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Social competence versus negative symptoms as predictors of real world social functioning in schizophrenia
- (2014) Belinda R. Robertson et al. SCHIZOPHRENIA RESEARCH
- Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
- (2014) Rachel Upthegrove et al. SCHIZOPHRENIA RESEARCH
- Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: Relationship to psychopathology
- (2014) Mei Hong Xiu et al. SCHIZOPHRENIA RESEARCH
- Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
- (2014) S G Fillman et al. Translational Psychiatry
- Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls
- (2013) Xiang Yang Zhang et al. BRAIN BEHAVIOR AND IMMUNITY
- Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial
- (2013) Sergi Mas et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Genome-wide association analysis identifies 13 new risk loci for schizophrenia
- (2013) Stephan Ripke et al. NATURE GENETICS
- Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms
- (2013) Alexander Stojanovic et al. PSYCHONEUROENDOCRINOLOGY
- Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response
- (2013) Milica Borovcanin et al. SCHIZOPHRENIA RESEARCH
- Converting positive and negative symptom scores between PANSS and SAPS/SANS
- (2013) Theo G.M. van Erp et al. SCHIZOPHRENIA RESEARCH
- Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features
- (2012) Clemente Garcia-Rizo et al. PSYCHIATRY RESEARCH
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- ELISA and Multiplex Technologies for Cytokine Measurement in Inflammation and Aging Research
- (2011) S. X. Leng et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- The environment and schizophrenia
- (2010) Jim van Os et al. NATURE
- Review of the operational definition for first-episode psychosis
- (2009) Nicholas J. K. Breitborde et al. Early Intervention in Psychiatry
- Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
- (2009) Akira Monji et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: Effects of antipsychotic drugs
- (2008) Benedicto Crespo-Facorro et al. PSYCHIATRY RESEARCH
- Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics
- (2008) Xiang Yang Zhang et al. PSYCHOPHARMACOLOGY
- Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
- (2008) G. Foussias et al. SCHIZOPHRENIA BULLETIN
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started